Table 2 Medical characteristics of patients receiving IN DAM
Variable; n (%) | Sample (n = 52) |
|---|---|
Age of first regular opioid use; M (SD)* | 20.9 (4.8) |
Duration of current HAT episode in years; M (SD)* | 8.6 (8.5) |
Duration of current HAT episode in years; MD (MIN MAX)* | 5.0 (0.0–28.0) |
History of non-prescribed IV substance use | 45 (86.5) |
Non-substance-related psychiatric comorbidities | |
None | 21 (40.4) |
One | 13 (25.0) |
Two or more | 18 (34.6) |
Non-opioid-related substance use disorders | |
Alcohol use disorder | 17 (32.7) |
Tobacco use disorder | 36 (69.2) |
Cocaine use disorder | 24 (46.2) |
Stimulant use disorder | 2 (3.8) |
Sedative use disorder | 21 (40.4) |
Cannabis use disorder | 19 (36.5) |
Medical comorbidities | |
HIV | 3 (5.8) |
Chronic hepatitis C-infection1 | 6 (11.5) |
Liver cirrhosis | 4 (7.7) |
Chronic obstructive pulmonary disease | 6 (11.5) |
Diabetes mellitus Type 2 | 4 (7.7) |
Long-term medication | |
Benzodiazepines | 27 (51.9) |
Stimulants | 6 (11.5) |
Other psychopharmacological medication | 24 (46.2) |
Other medication (except contraception) | 22 (42.3) |
Health system utilisation within the past year | |
Hospitalisation due to physical illness | 12 (23.1) |
Emergency room visit | 16 (30.8) |
Intensive care unit | 3 (5.8) |
Psychiatric inpatient stay | 5 (9.6) |
Involuntary psychiatric admission | 0 (0) |